1.Member States in whose territory the clinical trial takes place shall enter in a European database, accessible only to the competent authorities of the Member States, the Agency and the Commission:
(a)extracts from the request for authorisation referred to in Article 9(2);
(b)any amendments made to the request, as provided for in Article 9(3);